Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Candesartan and Amlodipine Combination Dose-Finding in Essential Hypertension
NCT02944734Phase 2Completed
- Sponsor
- Shinpoong Pharma
- Start
- Sep 2014
- Primary completion
- Dec 2015
- Modality
- Prodrugs/Conditional Activator Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of candesartan cilexetil, amlodipine in essential hypertension, sponsored by Shinpoong Pharma. Started Sep 2014; status: completed.
02
Drugs
candesartan cilexetilamlodipine
03
Conditions
essential hypertension
Beyond the preview
Go deeper on NCT02944734.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02944734.